Trial Profile
Phase 1/2 Trial of Ceftaroline for the Treatment of Hematogenously Acquired Staphylococcus Aureus Osteomyelitis in Children
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Ceftaroline fosamil (Primary)
- Indications Osteomyelitis; Staphylococcal infections
- Focus Adverse reactions
- 06 Jul 2020 Status changed from active, no longer recruiting to completed.
- 15 Apr 2020 Planned primary completion date changed from 1 Feb 2020 to 1 May 2020.
- 09 Nov 2018 Planned End Date changed from 1 Feb 2020 to 30 Jun 2020.